(2-Morpholin-2-yl-ethyl)-carbamic acid tert-butylester, 95.0%, 1g

4'-Nitrobenzanilide, 98.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-cyanophenyl)propanoic acid, 97%, 5g

4-Ethoxyphenylacetonitrile, 98.0%, 10g

5-Bromo-7-fluoro-2,3-dihydro-1H-inden-1-one, 95.0%, 25g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.50 µm, 1 Piece(s)

Carbimazole, 98.0%, 100g

Diphenyl hydrogen phosphate, 95.0%, 25g

1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-, 98%, 100mg

3-Bromo-4-chloro-6-ethoxyquinoline, 95.0%, 250mg

2-(10-Oxo-10,11-dihydrodibenzo[b,f]thiepin-2-yl)propanoic acid, 95.0%, 10g

Methyl 2-(4-bromophenyl)-2,2-dimethylacetate, 95.0%, 25g

5-Nitrouracil>99.0%(HPLC)(T)5g